Pfizer is expected to report its third-quarter results next month, and analysts are projecting a double-digit decline in its ...

What's the most attractive Big Pharma stock right now for investors? Seeking Alpha analysts weigh in. Read more here.

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ...

After a muted start to 2025, Big Pharma is back on the M&A trail. In just a month, three major players — Pfizer PFE, Novo ...

Pfizer acquired a smaller company for $4.9 billion to improve its prospects in the GLP-1 market. The pharmaceutical giant could carve out a small niche for itself in this growing space. Pfizer's ...

Fintel reports that on October 3, 2025, B of A Securities maintained coverage of Pfizer (NYSE:PFE) with a Neutral ...

CoreWeave, backed by Nvidia, gained 11.7% today after it secured a $14.2 billion long-term cloud deal with Meta platforms. This led to Nvidia stock rising 2.6%, a 52-week high for this tech stock.

Experts are sounding the alarm bell about a potential AI bubble burst sooner or later. But many believe major AI stocks still ...

The GLP-1 market has grabbed considerable attention in the past couple of years, and there's little doubt as to which pharmaceutical companies dominate this space. Eli Lilly is currently the leader, ...

Pfizer Inc. (NYSE: PFE) made a strong move higher after it became the first drug manufacturer to sign on as part of the ...

Markets continue to advance despite continuing concerns around valuations, inflation, and the deteriorating jobs market. Read what investors need to know.

Let's start with one of my favorite ultra-high-yielders, Ares Capital (NASDAQ: ARCC). This stock pays a forward dividend ...